(19)
(11) EP 3 830 103 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
20.12.2023 Bulletin 2023/51

(45) Mention of the grant of the patent:
08.11.2023 Bulletin 2023/45

(21) Application number: 19748933.9

(22) Date of filing: 30.07.2019
(51) International Patent Classification (IPC): 
C07J 41/00(2006.01)
A61P 1/16(2006.01)
C07J 11/00(2006.01)
C07J 71/00(2006.01)
 A61K 31/575(2006.01)
C07J 9/00(2006.01)
C07J 51/00(2006.01)
(52) Cooperative Patent Classification (CPC):
C07J 9/005; C07J 71/001; C07J 41/0055; C07J 51/00; C07J 41/0061; C07J 11/00
(86) International application number:
PCT/GB2019/052127
(87) International publication number:
WO 2020/025942 (06.02.2020 Gazette 2020/06)

(54)

FLUORINATED BILE ACID DERIVATIVES

FLUORIERTE GALLENSÄUREDERIVATE

DÉRIVÉS FLUORÉS D'ACIDE BILIAIRE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 30.07.2018 GB 201812382

(43) Date of publication of application:
09.06.2021 Bulletin 2021/23

(73) Proprietor: NZP UK Limited
Bristol, BS2 0ZX (GB)

(72) Inventors:
  • WEYMOUTH-WILSON, Alexander Charles
    Shinfield Berkshire RG2 9LH (GB)
  • PACKER, Gemma
    Shinfield Berkshire RG2 9LH (GB)
  • LINCLAU, Bruno Jan Pol
    Eastleigh Hampshire SO50 7PS (GB)
  • KYDD-SINCLAIR, Dannielle
    Reading, Berkshire RG6 6AH (GB)
  • WATSON, Kimberly Ann
    Reading, Berkshire RG6 6AH (GB)

(74) Representative: Sagittarius IP 
Marlow International Parkway
Marlow, SL7 1YL
Marlow, SL7 1YL (GB)


(56) References cited: : 
EP-A1- 3 290 429
WO-A1-2016/173493
 WO-A1-2016/073767
CN-A- 106 518 946
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).